- Home
- RLAY vs SR Comparison
RLAY vs SR Comparison
Compare RLAY & SR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLAY | SR |
|---|---|---|
| Founded | 2015 | 1857 |
| Country | United States | United States |
| Employees | N/A | 3497 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.7B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLAY | SR |
|---|---|---|
| Price | $20.01 | $80.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $19.50 | ★ $91.33 |
| AVG Volume (30 Days) | ★ 4.2M | 683.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.68% |
| EPS Growth | ★ 31.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,355,000.00 | N/A |
| Revenue This Year | N/A | $6.81 |
| Revenue Next Year | $324.03 | $2.31 |
| P/E Ratio | ★ N/A | $19.47 |
| Revenue Growth | ★ 53.44 | N/A |
| 52 Week Low | $3.03 | $71.24 |
| 52 Week High | $20.79 | $95.31 |
Technical Indicators
Market Signals| Indicator | RLAY | SR |
|---|---|---|
| Relative Strength Index (RSI) | 67.09 | 50.77 |
| Support Level | $12.10 | $77.84 |
| Resistance Level | N/A | $80.95 |
| Average True Range (ATR) | 1.31 | 1.73 |
| MACD | 0.17 | 0.54 |
| Stochastic Oscillator | 85.38 | 86.26 |
Price Performance
Historical ComparisonAbout RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.
About SR Spire Inc.
Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.